Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Ovarian Hyperstimulation Syndrome × Chorionic Gonadotropin × Gynecologic × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycystic Ovary Syndrome 2 Uterine Anomalies 1 Salpingitis 1 Primary Ovarian Insufficiency 1 Pregnancy, Ectopic 1 Ovarian Hyperstimulation Syndrome 1 Leiomyoma 1 Infertility, Female 1 Infertility 1 Endometritis 1 Endometriosis 1

Interventions

Triptorelin Pamoate 3 ganirelix 1 Profasi 1 Chorionic Gonadotropin 1 Cabergoline 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01815138 2018-10-26

Co-administration of Low Dose hCG at the Time of GnRH Agonist Trigger or 35 Hours Later for the Prevention of OHSS

UConn Health

Phase 4 Completed

89 enrolled 13 charts

Polycystic Ovary Syndrome, Ovarian Hyperstimulation Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡